These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15992737)

  • 21. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
    Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F
    Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is drug-induced long QT and what is a potential clinical consequence?
    Tsiperfal A; Gould M; Thompson C
    Prog Cardiovasc Nurs; 2006; 21(2):104-5. PubMed ID: 16760695
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonclinical proarrhythmia models: predicting Torsades de Pointes.
    Lawrence CL; Pollard CE; Hammond TG; Valentin JP
    J Pharmacol Toxicol Methods; 2005; 52(1):46-59. PubMed ID: 15975832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QRS fragmentation in acquired long QT syndrome does not always predict torsades of pointes tachycardia: a case report.
    Peters S
    Herz; 2014 Dec; 39(8):960-2. PubMed ID: 23949550
    [No Abstract]   [Full Text] [Related]  

  • 25. [Torsade de pointes and QT syndrome].
    Haverkamp W; Hördt M; Borggrefe M; Breithardt G
    Med Klin (Munich); 1995 Apr; 90(4):240-5. PubMed ID: 7776938
    [No Abstract]   [Full Text] [Related]  

  • 26. Torsade de pointes probably induced by sparfloxain.
    Ahluwalia G
    J Assoc Physicians India; 2003 Aug; 51():835; author reply 835. PubMed ID: 14651157
    [No Abstract]   [Full Text] [Related]  

  • 27. Sotalol unmasks susceptibility to drug-induced long QT syndrome and torsades de pointes.
    Letsas KP; Efremidis M; Sideris A
    Int J Cardiol; 2008 Mar; 124(3):366-7; author reply 368-9. PubMed ID: 17400314
    [No Abstract]   [Full Text] [Related]  

  • 28. Optimal location of the QT interval evaluation in patients with drug-induced QT prolongation and torsades de pointes: Limb leads, chest leads, or both?
    Lakkis B; Refaat MM
    J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2702-2703. PubMed ID: 32700425
    [No Abstract]   [Full Text] [Related]  

  • 29. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serious QT interval prolongation with ranolazine and amiodarone.
    Tarapués M; Cereza G; Arellano AL; Montané E; Figueras A
    Int J Cardiol; 2014 Mar; 172(1):e60-1. PubMed ID: 24424337
    [No Abstract]   [Full Text] [Related]  

  • 31. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.
    Wegener FT; Ehrlich JR; Hohnloser SH
    Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559
    [No Abstract]   [Full Text] [Related]  

  • 33. Droperidol-induced proarrhythmia: the beginning of an answer?
    Charbit B; Funck-Brentano C
    Anesthesiology; 2007 Oct; 107(4):524-6. PubMed ID: 17893444
    [No Abstract]   [Full Text] [Related]  

  • 34. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Conversion to sinus rhythm].
    Brunckhorst CB
    Praxis (Bern 1994); 2006 Feb; 95(7):247-8. PubMed ID: 16524116
    [No Abstract]   [Full Text] [Related]  

  • 37. Did you know? Why amiodarone requires diligent monitoring?
    Morris D; Cameron N
    Can J Cardiovasc Nurs; 2011; 21(4):3-6. PubMed ID: 22165500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diphenhydramine induced QT prolongation and torsade de pointes: An uncommon effect of a common drug.
    Husain Z; Hussain K; Nair R; Steinman R
    Cardiol J; 2010; 17(5):509-11. PubMed ID: 20865683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QT interval prolongation and Torsades de Pointes in a patient receiving zolpidem and amiodarone.
    Letsas KP; Filippatos GS; Kounas SP; Efremidis M; Sideris A; Kardaras F
    Cardiology; 2006; 105(3):146-7. PubMed ID: 16449812
    [No Abstract]   [Full Text] [Related]  

  • 40. Sulpiride induced torsade de pointes.
    Huang BH; Hsia CP; Chen CY
    Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.